Study objective: Subclavian vein cannulation in the infraclavicular region may be a preferred approach as it is associated with less infection than internal jugular or femoral venous access in critically ill patients. Short-axis view has a problem that shaft of the puncture needle is not visualized and tip of the needle is only seen as dot; hence posterior wall of the vein puncture is always possible with short-axis approach. We have designed this study to know the ultrasonographic anatomy of subclavian vein in short axis and medial oblique view. Design: Prospective randomized, cross-over. Setting: Operating room. Patients: One hundred consecutive patients aged between 18-50yrs of either sex, ASA PS I-III undergoing elective surgery under general anesthesia. Intervention: The ultrasonographic anatomy of axillary vein cannulation in infraclavicular region in one hundred patients was assessed as per randomization sequence in medial oblique probe position and short-axis probe position. Measurements: Antero-posterior and transverse diameter of axillary vein, pleural line visibility. Main Results: Transverse diameter of subclavian vein was higher in medial- oblique view [mean difference (95% confidence interval) 0.12 cm (0.09- 0.16) cm; p<0.0001]. However, mean (standard deviation) antero- posterior diameter was similar in two views [0.72(0.15) cm in short axis versus 0.68 (0.16) cm in medial oblique; p=0.07]. Visibility of pleural line was similar in both the view (p=0.84, Chi- square test). Conclusion: Medial-oblique view may be useful in axillary approach of subclavian vein cannulation. Further clinical studies are required to know whether medial oblique view can reduce complications and increase success rate of ultrasound guided subclavian vein cannulation over short axis view.

The authors have declared no competing interest.

CTRI/2017/12/010765

No funding was received

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Institute Ethics Committee, All India Institute of Medical Sciences, New Delhi, India (vide permission letter no: IEC- 580/05.01.2017).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors